The present study reveals a previously undescribed oncogenic mechanism by which p38-mediated EZH2 phosphorylation at T367 promotes breast cancer progression by inducing EZH2 cytoplasmic function and reducing nuclear EZH2 methyltransferase activity on histone H3K27. This evidence concerns the gene EZH2 and breast carcinoma.